A platform for sharing immunology data related to COVID-19.
Official title: THE IMMUNOLOGY DATABASE AND ANALYSIS PORTAL (IMMPORT)
NIH-11134472 · Data updated 2026-11-12
This study is working on a user-friendly online platform called ImmPort that shares important data about the immune system and COVID-19, helping researchers find new ways to improve treatments and understand these conditions better for everyone, including patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Project start | September 30, 2022 |
| Project end | September 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $240,064 |
| NIH project number | 316201200036W-P00005-759302200001-3 |
| Project ID | NIH-11134472 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals affected by COVID-19 or those involved in immunology studies.
✕Less likely to help
Patients who are not affected by COVID-19 or do not have an interest in immunology research may not receive any benefit from this research.
What this research studies
This research focuses on creating a publicly accessible data sharing platform called ImmPort, which supports immunology research and clinical studies. It provides curated datasets that follow the FAIR principles, ensuring that data is findable, accessible, interoperable, and reusable. The platform includes specific datasets like the 10K Immunomes Project and a COVID-19 compendium, which are designed to be AI-ready, facilitating advanced analysis and research. Patients may benefit from the insights generated through this data, which can inform better treatment strategies and understanding of COVID-19.
Why it matters
Potential benefit: If successful, this research could enhance the understanding of COVID-19 and improve treatment options for patients.
How similar studies have gone: Other research initiatives utilizing data sharing platforms have shown success in advancing medical knowledge and treatment options, indicating a promising approach.
Where this research is happening
Dulles, United States
Researchers
- Principal investigator: Butte, Atul
- Study coordinator: Butte, Atul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.